Jama Pediatrics

JAMA Pediatrics (jama-pediatrics)

Journal positioning

JAMA Pediatrics is a JAMA Network specialty journal for clinical and population research on the health of infants, children, and adolescents. It favors rigorous, practice- and policy-relevant work — randomized pediatric trials, large child-health cohorts and population studies, prevention and developmental research, and health- services analyses — with JAMA's emphasis on age-appropriate outcomes, adequate power, and direct relevance to child and adolescent care. Studies that simply extrapolate adult findings, small descriptive series, and work using adult-derived outcomes without pediatric validation are a weak fit. This skill is a fit / venue-selection / re-framing aid; it is not clinical or regulatory advice and does not replace the journal's current instructions for authors. Before submitting, re-check the live JAMA Pediatrics author instructions.

When to trigger

• The author names JAMA Pediatrics for a child- or adolescent-health clinical, developmental, or population study and wants a fit/framing check.
• A pediatric study must be re-framed around an age-appropriate, developmentally valid outcome for a child-health readership.
• The author is choosing between JAMA Pediatrics, JAMA, and a pediatric-subspecialty journal.
• The author needs the journal's pediatric-specific design, ethics (assent/parental consent), reporting-guideline, registration, and desk-reject expectations.

Scope & topic fit

• Randomized pediatric trials (therapeutic, behavioral, preventive, or vaccine) with age-appropriate primary outcomes, including pragmatic designs.
• Large child- and adolescent-health cohorts, birth cohorts, and population/registry studies with rigorous confounding control.
• Developmental, neurodevelopmental, growth, nutrition, and early-life-exposure studies with validated pediatric measures.
• Adolescent health, mental-health, injury-prevention, and child-maltreatment research with appropriate sensitivity and ethics.
• Pediatric health-services, quality, vaccine-policy, and disparities research.
• Systematic reviews and meta-analyses answering a focused child-health question.

Method & evidence bar

• Trials and studies must use age- and developmentally appropriate, validated outcome measures and be adequately powered; adult-derived endpoints need pediatric validation.
• The applicable reporting guideline and checklist are required: CONSORT for trials, STROBE for observational studies, PRISMA for systematic reviews; report stratification by age/developmental stage where relevant.
• Trials require prospective registration; registration number, protocol, and statistical-analysis plan are expected.
• Pediatric ethics must be explicit: IRB approval, parental/guardian permission, child assent appropriate to age, and protections for vulnerable populations (neonates, adolescents, maltreatment).
• Observational and exposure claims must address confounding, family clustering, and missing data; causal language must match the design.
• Long-term developmental outcomes need adequate follow-up and handling of attrition.

Structure & house style

• JAMA Network format with a structured abstract and a Key Points box; re-check current article types (Original Investigation, Brief Report, Research Letter, etc.) and limits on the live guide.
• The introduction frames a focused, child-health-relevant question; the discussion states the clinical, developmental, or policy implication plainly.
• Tables/figures follow JAMA Network statistical-reporting standards; CONSORT/STROBE flow diagrams and age-stratified results are expected where applicable.
• Supplements carry the protocol, SAP, consent/assent documentation summary, and additional analyses.